Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome-Reference-Cited by-同舟云学术

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Published:2020-07-04 Issue:1 Volume:56 Page:121-128
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Agrawal Vaibhav^ORCID,Ranganath Praveen,Ervin Kirsten D.,Schmidt Caitlin A.,Cox Elizabeth A.,Nelson Robert P.,Schwartz Jennifer E.,Zaid Mohammad Abu^ORCID,Abonour Rafat,Robertson Michael J.,Brinda Bryan J.,Griffin Shawn P.,Thakrar Teresa C.,Farag Sherif S.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0987-1.pdf

Reference35 articles.

1. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transpl. 2010;16:157–68. https://doi.org/10.1016/j.bbmt.2009.08.024. e-pub ahead of print 2009/09/22.

2. Carreras E, Diaz-Beya M, Rosinol L, Martinez C, Fernandez-Aviles F, Rovira M. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transpl. 2011;17:1713–20. https://doi.org/10.1016/j.bbmt.2011.06.006. e-pub ahead of print 2011/06/29.

3. Girinsky T, Benhamou E, Bourhis JH, Dhermain F, Guillot-Valls D, Ganansia V, et al. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol. 2000;18:981–6. https://doi.org/10.1200/JCO.2000.18.5.981. e-pub ahead of print 2000/03/01.

4. Kashyap A, Wingard J, Cagnoni P, Roy J, Tarantolo S, Hu W, et al. Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality. Biol Blood Marrow Transpl. 2002;8:493–500. https://doi.org/10.1053/bbmt.2002.v8.pm12374454. e-pub ahead of print 2002/10/11.

5. Petersdorf EW. HLA matching in allogeneic stem cell transplantation. Curr Opin Hematol. 2004;11:386–91. https://doi.org/10.1097/01.moh.0000143701.88042.d9. e-pub ahead of print 2004/11/19.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab;Transplantation and Cellular Therapy;2023-05